0001209191-20-013037.txt : 20200226
0001209191-20-013037.hdr.sgml : 20200226
20200226163736
ACCESSION NUMBER: 0001209191-20-013037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20656335
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Controller
Common Stock
2020-02-24
4
F
0
864
239.23
D
16012
D
Common Stock
2020-02-25
4
S
0
283
229.66
D
15729
D
Common Stock
2020-02-25
4
S
0
137
231.17
D
15592
D
Common Stock
2020-02-25
4
S
0
120
232.40
D
15472
D
Common Stock
2020-02-25
4
S
0
150
234.50
D
15322
D
Common Stock
2020-02-25
4
S
0
150
235.49
D
15172
D
Common Stock
2020-02-25
4
S
0
90
236.85
D
15082
D
Common Stock
2020-02-25
4
S
0
150
238.40
D
14932
D
Common Stock
169
I
401(k)
Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $229.66 (range $229.20 to $230.14).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $231.17 (range $230.73 to $231.47).
Open market sales reported on this line occurred at a weighted average price of $232.40 (range $232.37 to $232.44).
Open market sales reported on this line occurred at a weighted average price of $234.50 (range $234.14 to $235.10).
Open market sales reported on this line occurred at a weighted average price of $235.49 (range $235.15 to $235.87).
Open market sales reported on this line occurred at a weighted average price of $236.85 (range $236.65 to $237.24).
Open market sales reported on this line occurred at a weighted average price of $238.40 (range $238.19 to $238.54).
/s/ Omar White, Attorney-in-Fact
2020-02-26